ADRENALIGNE
ActiveSummary
The annual accounts of ADRENALIGNE for financial year 2025 show a net loss of 648% of total assets and of 93% of the equity at the start of that year. The 2025 annual accounts show equity of €278,374 and a net result of -€3.8m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 52% of 318 sector peers (NACE 58, financial year 2025). The company has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
- PHILIPPE - TOMEsubsidiaryEquity €68,185Result €56,218100%
According to the 2024 annual accounts of ADRENALIGNE and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 1 of 6 Gazette acts processed.